O'Neil Global Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
O'Neil Global Advisors's LLY Position: Q3 2026 in Review
O'Neil Global Advisors reduced its Eli Lilly (LLY) stake by 82% in Q3 2026, selling an estimated $77.3M and leaving 14,154 shares worth $16.4M. The position accounts for 6.28% of the portfolio, ranked #5.
O'Neil Global Advisors first reported a position in LLY in Q3 2022 and has held it in 7 quarters since. The position peaked at $95.6M in Q2 2026. 4,178 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- O'Neil Global Advisors held 14,154 shares of Eli Lilly worth $16.4M as of Q3 2026.
- O'Neil Global Advisors sold 65,524 Eli Lilly shares in Q3 2026, an estimated $77.3M.
- Eli Lilly made up 6.28% of O'Neil Global Advisors's portfolio in Q3 2026, its #5 holding.
- O'Neil Global Advisors first reported a position in Eli Lilly in Q3 2022 and has held it in 7 quarters since.
- O'Neil Global Advisors's Eli Lilly position peaked at $95.6M in Q2 2026.
- 4,178 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on O'Neil Global Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.